Suppr超能文献

白细胞介素-18 和凝胶蛋白与心脏导管检查后的急性肾损伤相关。

Interleukin-18 and Gelsolin Are Associated with Acute Kidney Disease after Cardiac Catheterization.

机构信息

Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

出版信息

Biomolecules. 2023 Mar 6;13(3):487. doi: 10.3390/biom13030487.

Abstract

Patients undergoing cardiac catheterization are at high risk of post-procedure acute kidney injury (AKI) and may experience persistent renal damage after an initial insult, a state known as acute kidney disease (AKD). However, the association between AKD and urinary renal biomarkers has not yet been evaluated in this population. We enrolled 94 patients who underwent elective cardiac catheterization to investigate patterns of urinary renal biomarkers and their associations with post-procedure AKD. Serial urinary renal biomarker levels were measured during pre-procedure, early post-procedure (12-24 h), and late post-procedure (7-10 days) periods. In our investigation, 42.55% of the enrolled patients developed AKD during the late post-procedure period. While the liver-type free-fatty-acid-binding protein level increased sharply during the early post-procedure period, it returned to baseline during the late post-procedure period. In contrast, interleukin-18 (IL-18) levels increased steadily during the post-procedure period. Early post-procedure ratios of IL-18 and gelsolin (GSN) were independently associated with subsequent AKD (odds ratio (95% confidence interval), 4.742 (1.523-14.759) for IL-18 ratio, = 0.007; 1.812 (1.027-3.198) for GSN ratio, = 0.040). In conclusion, post-procedure AKD is common and associated with early changes in urinary IL-18 and GSN in patients undergoing cardiac catheterization.

摘要

接受心脏导管检查的患者发生术后急性肾损伤(AKI)的风险较高,并且在最初损伤后可能会持续发生肾损伤,这种情况被称为急性肾脏病(AKD)。然而,在该人群中,尚未评估 AKD 与尿肾生物标志物之间的关系。我们招募了 94 例行择期心脏导管检查的患者,以研究尿肾生物标志物的模式及其与术后 AKD 的关系。在术前、术后早期(12-24 小时)和术后晚期(7-10 天)期间连续测量尿肾生物标志物水平。在我们的研究中,42.55%的入组患者在术后晚期发生 AKD。虽然肝型游离脂肪酸结合蛋白水平在术后早期急剧升高,但在术后晚期恢复至基线。相比之下,白细胞介素-18(IL-18)水平在整个术后期间持续稳定增加。术后早期的 IL-18 和明胶(GSN)比值与随后的 AKD 独立相关(比值比(95%置信区间),IL-18 比值为 4.742(1.523-14.759), = 0.007;GSN 比值为 1.812(1.027-3.198), = 0.040)。总之,心脏导管检查后 AKD 很常见,与术后 IL-18 和 GSN 尿中的早期变化相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ea/10046301/4fae0a67a1ae/biomolecules-13-00487-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验